Back to companies

Bioventus Inc.

BVSUSNASDAQPharmaceuticals & Healthcare

Bioventus Inc.

Revenue
$568.1mn
YoY -0.9%
Operating income
$54.0mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API